Increasing numbers of trials involving human subjects are being conducted at several centres simultaneously in the Netherlands. This multicentre research is, however, unnecessarily hampered by the major variation in procedures, processing times and costs of obtaining authorisation in each individual centre, even though it would not be difficult to streamline these essentially simple procedures and make them more transparent and cheaper.